Angiocrine Bioscience CEO and Key Executive Team

• Jeffrey L. Port

  Chairman & Co-Founder
• Shawn Sheeron

  Vice President, Clinical Operations
• Lee Landeen

  Executive Director, Pre-Clinical Development
• John R. Jaskowiak

  Chief Operating Officer
• Paul Finnegan

  Chief Executive Officer, Director
• Ronda Schreiber

  Senior Director, Technical Operations
• John K. Fraser

  Chief Scientific Officer
• John Lomoro

  Chief Financial Officer
• Michael Ginsberg

  Senior Director, Product Development
• Margie Breneman

  Senior Director, Project Management
• David R. Parkinson

  Director
• Jeannette Filippone

  General Counsel
• Martin B. Silverstein

  Director
• James Garmendia

  Director
• Daniel J. Nolan

  Director, External Research
• Jill Broadfoot

  Director
• Gayle Bresnahan

  Director, Clinical Operations

Source: angiocrinebioscience.com, angiocrinebioscience.com